Avenira Limited (ASX: AEV) (“Avenira” or “the Company”)”) has secured a Strategic Investment from its largest shareholder, Sichuan Hebang Biotechnology Corporation Limited (SHSE: 603077) (“Hebang”). HIGHLIGHTS: The Strategic Investment comprises:A$4.5 million 2-tranche Placement at an issue price of A$0.006 per new share, with Tranche 2 subject to shareholder approval and…
Zodiac Gold (TSXV:ZAU) is a West African gold exploration company developing a district-scale gold discovery in the Republic of…
Culpeo Minerals Limited (Culpeo or the Company) (ASX:CPO, OTCQB:CPORF) is pleased to announce it has received binding commitments from…
Bold Ventures management believes our suite of Battery, Critical and Precious Metals exploration projects are an ideal combination of…
E-Power Resources Inc. (CSE: EPR) (‘E-Power’ or the ‘Company’) is pleased to report results from the first phase of…
Prices for Brent and West Texas crude consolidated through the second quarter of 2024, shedding 2.68 percent and 2.45…
Brightstar Resources Ltd (ASX: BTR) (Brightstar) is pleased to announce it has received firm commitments to raise approximately $24…
Galan Lithium Limited (ASX: GLN) (Galan or the Company) is pleased to announce that it has utilised its At-the-Market…
High-Tech Metals Limited (ASX: HTM) (High-Tech, HTM or the Company), refers to the announcement dated 6 September 2023 regarding…